Definition
- Essential:
- Papillary growth pattern with epithelial-like cells AND
- Characteristic immunohistochemical staining pattern (e.g. positivity for cytokeratins, SPDEF, CD56) AND
- Pineal region location AND (for unresolved cases)
- Confirmatory DNA methylation profiling
Numbers
- Mean age 35 yrs
- M:F ratio of 1.06:1
- 181 case reported
Localisation
- As above
Cell origin
- Arise from specialised ependymocytes of the subcommissural organ located in the lining of the posterior commissure rather than from the pineal gland itself
- PPTs
CNS WHO grading
- Grade 2 or 3
- Definitive histological grading not out yet
Histopathology
Macroscopy
- Well circumscribed
- They are grossly indistinguishable from pineocytomas
Microscopy
- Has both epithelial and papillary features
- Variable morphology ranging from solid to predominantly papillary, reminiscent of ependymomas (true rosettes and tubes).
Immunophenotype
- Cytokeratins (AE1/3, CAM5.2, KL1, CK18): positive in papillary structure
- S100: positive
- Vimentin: positive
- Tansthyretin: positive
- Neurone-specific enolase: positive
- MAP2: positive
- GFAP: variable
Genetic profile
- DNA methylation profiles differentiating papillary tumours of the pineal region from ependymomas
- No expression of the V600Emutant BRAF protein
Clinical presentation
- Compression of pineal s(x)
- Cerebral aqueduct:
- Obstruction HCP
- Papilledema
- H/A
- Ataxia
- Impaired vision
- N/V
- Brain stem
- Tectal plate compression: Parinaud syndrome
- Loss of upward gaze
- Cerebellum
- Dizziness
- Tremor
- Endocrine
- Diabetes insipidus
- Present with DI because it infiltrates the floor of 3rd ventricle affecting the pituitary
- Precocious puberty
- Acute clinical presentation can be due to tumour apoplectic
Radiological
- MRI
- Papillary tumours of the pineal region are often indistinguishable from pineocytomas.
Images
Prognosis
- Overall survival is 73% at 5 years and 71.6% at 10 years.
- Progression free survival is 27%
- Tendency for recurrence and need for repeated surgery
- 57% local recurrence
- Screening of the entire neural axis is required as CSF dissemination has been reported in up to 7% of cases
- Good prognostic value
- Young patients
- Gross total resection
- Fauchon 2013: No effect on survival
- Chemo/radiotherapy
- Poor prognostic value
- High mitotic rate
- >3 mitosis per 10 high power fields: 52 months vs 68 months
- Ki67>10% vs <10% → median progression free survival time of 29 month vs67 months